Epidermolysis bullosa acquisita explained

Epidermolysis bullosa acquisita
Synonyms:Acquired epidermolysis bullosa

Epidermolysis bullosa acquisita, also known as acquired epidermolysis bullosa, is a longterm autoimmune blistering skin disease.[1] It generally presents with fragile skin that blisters and becomes red with or without trauma.[2] Marked scarring is left with thin skin, milia and nail changes.[3] It typically begins around age 50.[2]

It is caused by antibodies to type VII collagen within anchoring fibril structures located at the dermoepidermal junction in skin.[3] Damaged skin may become infected.[3]

Diagnosis is by observing the persistence of the condition, direct immunofluorescence, and detecting autoantibodies against type VII collagen.[2] It can appear similar to porphyria cutanea tarda, pemphigoid, pemphigus, dermatitis herpetiformis, or blistering drug eruption.[3] The condition is longterm and has no cure.[1] A good response may be seen with corticosteroids, either alone or combined with azathioprine or dapsone.[3]

It is rare, with around 0.08 to 0.5 new cases per million people per year, and it affects males and females equally.[2]

Signs and symptoms

It generally presents with fragile skin that blisters and becomes red with or without trauma.[2] Marked scarring is left with thin skin, milia and nail changes.[3] It typically begins around age 50.[2]

Cause

It is caused by antibodies to type VII collagen within anchoring fibril structures located at the dermoepidermal junction in skin.[3]

Diagnosis

Diagnosis is by observing the persistence of the condition, direct immunofluorescence, and detecting autoantibodies against type VII collagen.[2] It can appear similar to porphyria cutanea tarda, pemphigoid, pemphigus, dermatitis herpetiformis, or blistering drug eruption.[3]

Treatment

The condition is longterm and has no cure.[1] A good response may be seen with corticosteroids, either alone or combined with azathioprine or dapsone.[3]

Epidemiology

It is rare, with around 0.08 to 0.5 new cases per million people per year, and it affects males and females equally.[2]

See also

Notes and References

  1. Web site: Orphanet: Acquired epidermolysis bullosa . www.orpha.net . 19 April 2019 . en . 30 July 2017 . https://web.archive.org/web/20170730134803/http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=46487 . live .
  2. Kridin . Khalaf . Kneiber . Diana . Kowalski . Eric H. . Valdebran . Manuel . Amber . Kyle T. . Epidermolysis bullosa acquisita: A comprehensive review . Autoimmunity Reviews . August 2019 . 18 . 8 . 786–795 . 10.1016/j.autrev.2019.06.007 . 31181325 . 184486635 . 1873-0183.
  3. Book: James . William D. . Elston . Dirk . Treat . James R. . Rosenbach . Misha A. . Neuhaus . Isaac . Andrews' Diseases of the Skin: Clinical Dermatology . 2020 . Elsevier . Edinburgh . 978-0-323-54753-6 . 468-469 . 13th . https://books.google.com/books?id=UEaEDwAAQBAJ&dq=Chronic+blistering&pg=PA468 . en . 21. Chronic blistering dermatoses.